Recombinant bacteria for fine regulation and control of saccharomyces cerevisiae ERG7 expression and construction method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- TIANJIN UNIV
- Publication Date
- 2019-12-31
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of bioengineering, and in particular relates to a recombinant bacterium and a construction method for finely regulating the expression of Saccharomyces cerevisiae ERG7. Background technique
[0002] Triterpenoids, such as protopanaxadiol, oleanolic acid, glycyrrhetinic acid, betulinic acid, ursolic acid, etc., are the main components of many Chinese herbal medicines to exert their medicinal activities, and are widely used in medicine, health products and food fields . At present, such compound products are mainly obtained through plant extraction. Taking protopanaxadiol as an example, ginsenosides in ginseng are extracted, and then obtained through acid-base hydrolysis or enzymatic hydrolysis. Traditional production methods have low extraction efficiency, long production cycle, high cost and great damage to the environment, which are far from meeting the demand for triterpenoids in the chemical and pharmace...